AQUACEL™ Ag+ Dressings
AQUACEL™ Ag+ dressings are antimicrobial primary dressings for use in wounds that are infected or at risk of infection. They are designed to manage the 3 key local barriers to healing - exudate, infection and biofilm. AQUACEL™ Ag+ dressings incorporate proven Hydrofiber™ Technology and Ag+ Technology - a unique ionic silver-containing, antibiofilm formulation.1 AQUACEL™ Ag+ dressings are available as AQUACEL™ Ag+ Extra and AQUACEL™ Ag+ Ribbon dressings.
AQUACEL™ Ag+ Extra dressing is comprised of 2 layers of Hydrofiber Technology stitch bonded together making it 9x stronger and 50% more absorbent than standard AQUACEL™ Ag dressing.2
AQUACEL™ Ag+ Ribbon dressing is also strengthened with stitchbonding.
- 5x5cm (2" x 2")
- 10 per box
- 10x10cm (4" x 4")
- 10 per box
- 15x15cm (5.9" x 5.9")
- 5 per box
- 20x30cm (8" x 12")
- 5 per box
- 4x10cm (1½" x 4")
- 10 per box
Ag+ Technology is a unique ionic silver-containing, antibiofilm formulation that:*1
- Disrupts and beaks down biofilm slime ro expose bateria3-5
- Kills a broad spectrum of bacteria, including antibiotic resistant superbugs, with its reservoir of silver *4,5,6
- Prevents biofilm formation*4,5
Hydrofiber™ Technology helps create an ideal environment for healing – and for Ag+ Technology to work.
- Locks in excess exudate, bacteria and biofilm to help minimise cross infection and prevent maceration*7-12
- Micro contours to the wound bed, maintaining optimal moisture balance and eliminating dead spaces where bacteria and biofilm can grow*13-15
- Responds to wound conditions by forming a cohesive gel, while helping to minimise pain associated with dressing changes*16-18
AQUACEL™ Ag+ Extra™ dressing my be used for the management of:
- wounds as a barrier to bacterial penetration of the dressing as this may help reduce infection;
- wounds where there is an infection or an increased risk of infection;
- diabetic foot ulcers, leg ulcers, (venous stasis ulcers, arterial ulcers and leg ulcers of mixed aetiology) and pressure ulcers/sores (partial & full thickness);
- surgical wounds;
- traumatic wounds;
- wounds that are prone to bleeding, such as wounds that have been mechanically or surgically debrided;
- oncology wounds with exudate, such as fungoides-cutaneous tumors, fungating carcinoma, cutaneous metastasis, Kaposi’s sarcoma, and angiosarcoma;
- wounds where bacteria are a suspected cause of (or a factor in) chronicity /non-progression.
In addition, AQUACEL™ Ag+ Ribbon dressing may be used for cavity and deepwounds including sinus, undermining and trackingwounds.
*As demonstrated in vitro
1. Composition comprising antimicrobial metal ions and a quaternary cationic surfactant. Scientific Background Report. WO 2012136968 A1, 2012, Data on file, ConvaTec Inc.
2 - Assessment of the in vitro Physical Properties of AQUACEL EXTRA, AQUACEL Ag EXTRA and AQUACEL Ag+ EXTRA dressings. Scientific background report. WHRIA3817 TA297, 2013, Data on File, ConvaTec Inc.
3. Physical Disruption of Biofilm by AQUACEL® Ag+ Wound Dressing. Scientific Background Report. WHRI3850 MA232, 2013, Data on file, ConvaTec Inc.
4. Antimicrobial activity and prevention of biofilm reformation by AQUACEL™ Ag+ EXTRA dressing. Scientific Background Report. WHRI3857 MA236, 2013, Data on file, ConvaTec Inc.
5. Antimicrobial activity against CA-MRSA and prevention of biofilm reformation by AQUACEL™ Ag+ EXTRA dressing. Scientific Background Report. WHRI3875 MA239, 2013, Data on file, ConvaTec Inc.
6. Bowler PG, Welsby S, Towers V, Booth V, Hogarth A, Rowlands V, Joseph A, et al, 2012. Multidrug-resistant organisms, wounds and topical antimicrobial protection. Int Wound J. 9: 387-396.
7. Newman GR, Walker M, Hobot JA, Bowler PG, 2006. Visualisation of bacterial sequestration and bacterial activity within hydrating Hydrober™ wound dressings. Biomaterials; 27:1129-1139.
8. Walker M, Hobot JA, Newman GR, Bowler PG, 2003. Scanning electron microscopic examination of bacterial immobilization in a carboxymethyl cellulose (AQUACEL™) and alginate dressing. Biomaterials; 24: 883-890.
9. Bowler PG, Jones SA, Davies BJ, Coyle E, 1999. Infection control properties of some wound dressings. J. Wound Care; 8: 499-502.
10. Walker M, Bowler PG, Cochrane CA, 2007. In vitro studies to show sequestration of matrix metalloproteinases by silver-containing wound care products. Ostomy/Wound Management. 2007; 53: 18-25.
11. Walker M and Parsons D, 2010. Hydrofiber Technology: its role in exudate management. Wounds UK; 6: 31-38.
12. Parsons D, Bowler PG, Myles V, Jones SA, 2005. Silver antimicrobial dressings in wound management: A comparison of antibacterial, physical and chemical characteristics. WOUNDS;17: 222-232.
13. Jones SA, Bowler PG, Walker M, 2005. Antimicrobial activity of silver-containing dressings is influenced by dressing conformability with a wound surface. WOUNDS; 17: 263-270.
14. Bowler P, Jones S, Towers V, Booth R, Parsons D, Walker M, 2010. Dressing conformability and silver-containing wound dressings. Wounds UK; 6: 14-20.
15. Walker M, Jones S, Parsons D, Booth R, Cochrane C, Bowler P, 2011. Evaluation of low-adherent antimicrobial dressings. Wounds UK; 7: 32-45.
16. Barnea Y, Armir A, Leshem D, Zaretski A, Weiss J, Shafir R, et al, 2004. Clinical comparative study of Aquacel and paraffin gauze dressing for split-skin donor site treatment. Ann Plast Surg; 53: 132-136.
17. Kogan L, Moldavsky M, Szvalb S, Govrin-Yehudain J, 2004. Comparative study of Aquacel and Silverol treatment in burns. Ann Burns Fire Disasters; 17: 201-207.
18. Brunner U, Eberlein T, 2000. Experiences with hydrofibres in the moist treatment of chronic wounds, in particular of diabetic foot. VASA; 29: 253-257.